Product Pipeline
Corixa Executive Management Team

Steven Gillis, Ph.D.
Chairman and Chief Executive Officer, Corixa Corporation
Kenneth Grabstein, Ph.D
Executive Vice President, Director of Immunology
Steven Reed, Ph.D.
Executive Vice President and Chief Scientific Officer
Michelle Burris
Senior Vice President, Chief Financial Officer
David Fanning
Senior Vice President, Chief Operating Officer
Cindy Jacobs, M.D., Ph.D.
Senior Vice President, Director of Clinical Research
Kathleen McKereghan
Senior Vice President, General Counsel and Secretary
Charles Richardson, Ph.D.
Senior Vice President and Site Manager -- Hamilton
Corixa Management Team

Martin Cheever, M.D.
Vice President, Director of Medical Affairs
Gary Christianson
Vice President, Technical Operations
William Derrick
Vice President, Chief Information Officer
Monica Krieger
Vice President, Regulatory Affairs
Bernie Paul
Vice President, Human Resources
David Persing, M.D., Ph.D.
Vice President, Antigen Discovery and Diagnostics Development
Corixa Board of Directors

Steven Gillis, Ph.D.
Chairman, Chief Executive Officer and Chairman of the Board, Corixa Corporation
Michael F. Bigham
Vice Chairman of the Board of Directors
Joseph L. Lacob
General Partner, Kleiner Perkins Caufield & Byers
Mark McDade
Chief Executive Officer, Signature Bioscience
Robert Momsen
General Partner, InterWest Partners
Arnold Oronsky, Ph.D.
General Partner, InterWest Partners
Samuel Saks, M.D.
Company Group Chairman, ALZA Corporation
James W. Young, Ph.D.
Chief Executive Officer, Sunesis Pharmaceuticals
Steven Gillis, Ph.D.
Steven Gillis, Ph.D., co-founded Corixa in October 1994 and has served as Chief Executive Officer and as a director of Corixa since then. Dr. Gillis has served as the Chairman of our Board of Directors since March 1999. From 1994 to February 1999, Dr. Gillis served as our president. Dr. Gillis was a co-founder of Immunex, where he held multiple positions, including acting Chief Executive Officer and Chairman of the Board. In addition, Dr. Gillis is a director of both Micrologix Biotech and Genesis Research and Development Corporation. He also serves on the scientific advisory board of Medarex. Dr. Gillis graduated from Williams College and received his Ph.D. from Dartmouth College.
Kenneth Grabstein, Ph.D
Kenneth Grabstein, Ph.D. co-founded Corixa in October 1994 and has served as Corixa's director of immunology since that time. He also serves as our executive vice president, a position he has held since March 1999. From 1994 to February 1999, he served as Corixa's vice president. Prior to co-founding Corixa, Dr. Grabstein was the director of cellular immunology and director of the flow cytometry facility at Immunex. He has also served as an affiliate investigator of the Clinical Research Division of the Fred Hutchinson Cancer Research Center. Dr. Grabstein graduated from the University of California, Berkeley and received his Ph.D. from the University of California, Berkeley.
Steven Reed, Ph.D.
Steven Reed, Ph.D. co-founded Corixa in October 1994 and has served as Corixa's executive vice president and chief scientific officer since then. Dr. Reed also serves as a professor of pathobiology at the University of Washington. Prior to co-founding Corixa, he founded the Infectious Disease Research Institute and also served as a senior scientist at the Seattle Biomedical Research Institute. Dr. Reed graduated from Whitman College and received his Ph.D. from the University of Montana.
Michelle Burris
Michelle Burris has served as Corixa's senior vice president and chief financial officer since January 2001. From January 1998 until December 2000, Ms. Burris served as vice president and chief financial officer. From February 1997 to January 1998, she was vice president of finance and administration. From 1996 to February 1997, she served as our director of finance and administration, and from 1995 to 1996, she was Corixa's controller. Ms. Burris served Corixa as a consultant from November 1994 through March 1995. Before working with us, Ms. Burris held several finance and planning positions at The Boeing Company. Ms. Burris is a Certified Public Accountant, and she graduated from George Mason University and received her M.B.A. from Seattle University.
David Fanning
Dave Fanning rejoined Corixa in October 2001 after serving as Chief Business Officer for CoPharma, Inc. where he led partnering efforts for the company's lead products in dermatology, cardiovascular disease and oncology, as well as managed the growth of the company's manufacturing business. Prior to joining CoPharma, Mr. Fanning served as Vice President, Business Development and Marketing for Corixa. In that role, Mr. Fanning was instrumental in executing Corixa's business development strategy in which he negotiated and/or managed numerous major research and development collaborations with U.S. and international pharmaceutical companies. Mr. Fanning received his bachelor's degree from Harvard University and an M.B.A. from the MIT Sloan School of Management.
Cindy Jacobs, M.D., Ph.D.
Cindy Jacobs, Ph.D., M.D. has served as Corixa's senior vice president, clinical research since January 2001. From April 1999 until December 2000, Dr. Jacobs served as vice president and director of clinical research. Prior to joining Corixa, Dr. Jacobs served as the vice president of clinical research at Cytran. From 1993 to 1998, Dr. Jacobs was director of clinical research at CellPro, where she held various positions including vice president of clinical research. Dr. Jacobs graduated from Montana State University. She received her M.S. from Washington State University, her Ph.D. from Washington State University and her M.D. from the University of Washington.
Kathleen McKereghan
Kathleen McKereghan has served as Corixa's senior vice president and general counsel since January 2001. From January 2000 to December 2000 she served as vice president and general counsel and as Corixa's corporate secretary since June 1998. From January 1998 to January 2000, she served as Corixa's director of legal affairs, and from December 1995 to January 1998 she was Corixa's corporate attorney. Prior to joining, Ms. McKereghan practiced law at the law firm of Perkins Coie in Seattle, Washington. Ms. McKereghan is a member of the board of directors of LigoCyte Pharmaceuticals. Ms. McKereghan graduated from the University of California, Davis and received her J.D. from the University of Washington.
Charles Richardson, Ph.D.
Charles Richardson, Ph.D. has served as Corixa's senior vice president, site manager since January 2001. He served as vice president and general manager at Corixa's Hamilton, Montana facility from October 1999 until December 2000. From 1988 to 1999, Dr. Richardson served in various capacities at Ribi ImmunoChem Research, including vice president of pharmaceutical discovery. He graduated from Carnegie Mellon University and received his Ph.D. from the University of Cincinnati.
A business overview as well as information on Corixa's partners, management team, employment opportunities, and company contacts.
Corixa's near-term products and adjuvant for research applications.
Product pipeline, therapeutic areas of focus, products, technology platforms, and publications.
Company reports, stockholder letter, events calendar, stock quote, analyst list, and materials request.
Current and archived company press releases.
A business overview as well as information on Corixa's partners, management team, employment opportunities, and company contacts.